Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsy...

by Schreiner, A, Bergmans, P, Cherubin, P, Keim, S, Llorca, P-M, Cosar, B, Petralia, A, Corrivetti, G, Hargarter, L
Published 2015

A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia

by Le Clerc, S, Taing, L, Fond, G, Meary, A, Llorca, P-M, Blanc, O, Beaune, P, Rajagopal, K, Jamain, S, Tamouza, R, Zagury, J-F, Leboyer, M
Published 2015

Hallucinations in schizophrenia and Parkinson’s disease: an analysis of sensory modalities involved and the repercussion on patients

by Llorca, P. M., Pereira, B., Jardri, R., Chereau-Boudet, I., Brousse, G., Misdrahi, D., Fénelon, G., Tronche, A.-M., Schwan, R., Lançon, C., Marques, A., Ulla, M., Derost, P., Debilly, B., Durif, F., de Chazeron, I.
Published 2016